Suchergebnisse - "Fabricius, Katrine"

PubPharm (47)

1

Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease

enthalten in: Disease models & mechanisms | 2019

von Roostalu, U. | Salinas, C. | Thorbek, D. | +10

2

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

enthalten in: Scientific reports | 2019

von Madsen, M. | Holm, J. | Pallejà, A. | +9

3

Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2019

von Bech, E. | Voldum-Clausen, K. | Pedersen, S. | +4

4

Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells

enthalten in: Frontiers in neuroscience | 2019

von Kaalund, S. | Johansen, A. | Fabricius, K. | +1

5

Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control

enthalten in: Peptides | 2018

von Fernandez-Cachon, M. | Pedersen, S. | Rigbolt, K. | +23

6

Neocortical Development in Brain of Young Children-A Stereological Study

enthalten in: Cerebral cortex (New York, N.Y. : 1991) | 2017

von Kjær, M. | Fabricius, K. | Sigaard, R. | +1

7

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease

enthalten in: Frontiers in neuroanatomy | 2017

von Fabricius, K. | Barkholt, P. | Jelsing, J. | +1

8

Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease

enthalten in: Brain research | 2016

von Hansen, H. | Fabricius, K. | Barkholt, P. | +5

9

The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy

enthalten in: Brain research | 2016

von Hansen, H. | Barkholt, P. | Fabricius, K. | +5

10

Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease

enthalten in: PloS one | 2016

von Hansen, H. | Fabricius, K. | Barkholt, P. | +8

1
2
3
4
5
Nächster »
[5]